Dual Delivery of rhPDGF-BB and Bone Marrow Mesenchymal Stromal Cells Expressing the BMP2 Gene Enhance Bone Formation in a Critical-Sized Defect Model

• Published in: Tissue engineering. Part A Vol. 19; no. 21-22; pp. 2495 - 2505
• Main Authors: Park, Shin-Young, Kim, Kyoung-Hwa, Shin, Seung-Yun, Koo, Ki-Tae, Lee, Yong-Moo, Seol, Yang-Jo
• Format: Journal Article
• Language: English
• Published: United States Mary Ann Liebert, Inc 01.11.2013
• Subjects: Animals; Bone Marrow Cells - cytology; Bone Marrow Cells - metabolism; Bone Morphogenetic Protein 2 - genetics; Bone Morphogenetic Protein 2 - metabolism; Bones; Cell growth; Cell Proliferation; Cells, Cultured; Gene expression; Humans; Male; Mesenchymal Stromal Cells - cytology; Original; Original Articles; Osteogenesis - physiology; Proteins; Proto-Oncogene Proteins c-sis - metabolism; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Stem cells; Tissue engineering
• ISSN: 1937-3341; 1937-335X
• DOI: 10.1089/ten.tea.2012.0648

Bone tissue healing is a dynamic, orchestrated process that relies on multiple growth factors and cell types. Platelet-derived growth factor-BB (PDGF-BB) is released from platelets at wound sites and induces cellular migration and proliferation necessary for bone regeneration in the early healing process. Bone morphogenetic protein-2 (BMP-2), the most potent osteogenic differentiation inducer, directs new bone formation at the sites of bone defects. This study evaluated a combinatorial treatment protocol of PDGF-BB and BMP-2 on bone healing in a critical-sized defect model. To mimic the bone tissue healing process, a dual delivery approach was designed to deliver the rhPDGF-BB protein transiently during the early healing phase, whereas BMP-2 was supplied by rat bone marrow stromal cells (BMSCs) transfected with an adenoviral vector containing the BMP2 gene (AdBMP2) for prolonged release throughout the healing process. In in vitro experiments, the dual delivery of rhPDGF-BB and BMP2 significantly enhanced cell proliferation. However, the osteogenic differentiation of BMSCs was significantly suppressed even though the amount of BMP-2 secreted by the AdBMP2-transfected BMSCs was not significantly affected by the rhPDGF-BB treatment. In addition, dual delivery inhibited the mRNA expression of BMP receptor type II and Noggin in BMSCs. In in vivo experiments, critical-sized calvarial defects in rats showed enhanced bone regeneration by dual delivery of autologous AdBMP2-transfected BMSCs and rhPDGF-BB in both the amount of new bone formed and the bone mineral density. These enhancements in bone regeneration were greater than those observed in the group treated with AdBMP2-transfected BMSCs alone. In conclusion, the dual delivery of rhPDGF-BB and AdBMP2-transfected BMSCs improved the quality of the regenerated bone, possibly due to the modulation of PDGF-BB on BMP-2-induced osteogenesis.